Find information on thousands of medical conditions and prescription drugs.

Lipidil

Lipidil (Fenofibrate) belongs to the class of medications known as fibrates, which are used to lower elevated serum lipids by decreasing the low density lipoprotein (LDL) fraction rich in cholesterol and the very low density lipoprotein (VLDL) fraction rich in triglycerides. In addition, fenofibrate increases the high density lipoprotein (HDL) cholesterol fraction and seem to improve insulin resistance when the dyslipidemia is associated with other features of Syndrome X (Hypertension and Diabetes Mellitus-Type 2). more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
Labetalol
Lacrisert
Lactitol
Lactuca virosa
Lactulose
Lamictal
Lamisil
Lamivudine
Lamotrigine
Lanophyllin
Lansoprazole
Lantus
Lariam
Larotid
Lasix
Latanoprost
Lescol
Letrozole
Leucine
Leucovorin
Leukeran
Levaquin
Levetiracetam
Levitra
Levocabastine
Levocetirizine
Levodopa
Levofloxacin
Levomenol
Levomepromazine
Levonorgestrel
Levonorgestrel
Levophed
Levora
Levothyroxine sodium
Levoxyl
Levulan
Lexapro
Lexiva
Librium
Lidocaine
Lidopen
Linezolid
Liothyronine
Liothyronine Sodium
Lipidil
Lipitor
Lisinopril
Lithane
Lithobid
Lithonate
Lithostat
Lithotabs
Livostin
Lodine
Loestrin
Lomotil
Loperamide
Lopressor
Loracarbef
Loratadine
Loratadine
Lorazepam
Lortab
Losartan
Lotensin
Lotrel
Lotronex
Lotusate
Lovastatin
Lovenox
Loxapine
LSD
Ludiomil
Lufenuron
Lupron
Lutropin alfa
Luvox
Luxiq
Theophylline
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Lipidil specifically is used to combat hyperlipidemia (high cholesterol in the blood), usually in conjunction with a statin drug such as Lipitor. This may help prevent the development of pancreatitis (inflammation of the pancreas).

Side effects:

Lipidil, like most fibrates, can cause stomach upsets and myopathy (muscle pain). Long term use can cause liver damage and renal (kidney) failure.

Read more at Wikipedia.org


[List your site here Free!]



Varying effects of lipid drugs on overall mortality rates
Clinical Question: What methods of lipid lowering decrease overall mortality rates in patients with hyperlipidemia? Setting: Various (meta-analysis) ...
New drugs in the long-term care setting, part 1: a quick look at the benefits, uses and abuses of some recent candidates for LTC formularies - Feature
Lost in all the current debate over PPS, RUGs and prescription drug coverage is the fact that the pharmaceutical industry continues to make progress ...
Nine Steps To A Healthier Heart
Here's our simplified version of the "Quick Desk Reference" for physicians published by the National Cholesterol Education Program (NCEP).(1) 1 step ...
Unscrambling dangerous myths about heart disease
SOME PATIENTS have gotten the facts about heart disease scrambled; believing the common myths listed below can be hazardous to their health. Here's the ...
Tricor OK'd for marketing
Tricor (micronized fenofibrate), Abbott Laboratories and Groupe Fournier's triglyceride-lowering agent already marketed elsewhere in the world as Lipanthyl ...
Abbott Statement on FIELD Study Presented at American Heart Association Meeting and Published in The Lancet
ABBOTT PARK, Ill., Nov. 14 /PRNewswire-FirstCall/ -- In response to data on the FIELD trial being presented at a late-breaking session of the American ...
Biovail Corp. And Fournier Pharma Sign Co-Promotion Agreement
TORONTO--(BW HealthWire)--Dec. 17, 1997--Biovail Corporation International (NYSE, TSE:BVF) today announced that its Canadian sales and marketing subsidiary, ...

Home Contact Resources Exchange Links ebay